The REMODEL trial testing semaglutide’s efficacy in patients with CKD and T2DM also employed MRI, transcriptomics, blood and urine samples, and kidney biopsies to clarify the drug’s effects.
CVOT, notable for comparing the two drugs, tirzepatide showed significantly greater improvements in major kidney outcomes vs dulaglutide.
Rilparencel, a percutaneous minimally invasive injectable product prepared from patients’ own kidney cells, is being developed to treat those with stage 3b or 4 CKD and either type 1 or type 2 ...
Doctors at New York University say two new studies show that they are a significant step closer to making cross-species ...
MedPage Today on MSN
Conservative Dialysis Feasible in Acute Kidney Injury, Trial Suggests
HOUSTON -- A conservative dialysis strategy improved rates of kidney function compared to conventional thrice-weekly dialysis in patients with acute kidney injury (AKI) undergoing kidney replacement ...
According to the report, in 2023, approximately 13.8 crore Indians were affected by the condition, second only to China’s 15.2 crore ...
First lady Melania Trump, 48, underwent an embolization procedure Monday morning at Walter Reed National Military Medical Center to treat a benign kidney condition, according to a statement issued by ...
First lady Melania Trump, 48, underwent an embolization procedure Monday morning at Walter Reed National Military Medical Center to treat a benign kidney condition, according to a statement issued by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback